Pharmasaga Co. Ltd. (TPEX:7878)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
299.50
0.00 (0.00%)
At close: Feb 11, 2026

Pharmasaga Statistics

Total Valuation

Pharmasaga has a market cap or net worth of TWD 16.03 billion. The enterprise value is 15.86 billion.

Market Cap 16.03B
Enterprise Value 15.86B

Important Dates

Earnings Date n/a
Ex-Dividend Date n/a

Share Statistics

Pharmasaga has 53.54 million shares outstanding.

Current Share Class 53.54M
Shares Outstanding 53.54M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 17.50%
Owned by Institutions (%) 7.26%
Float 42.06M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
PB Ratio 61.40
P/TBV Ratio 86.36
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a

Enterprise Valuation

EV / Earnings -196.05
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.03, with a Debt / Equity ratio of 0.00.

Current Ratio 13.03
Quick Ratio 12.75
Debt / Equity 0.00
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -3,397.04

Financial Efficiency

Return on equity (ROE) is -32.86% and return on invested capital (ROIC) is -23.28%.

Return on Equity (ROE) -32.86%
Return on Assets (ROA) -22.34%
Return on Invested Capital (ROIC) -23.28%
Return on Capital Employed (ROCE) -35.12%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -8.99M
Employee Count 9
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 273.06
200-Day Moving Average n/a
Relative Strength Index (RSI) 49.77
Average Volume (20 Days) 436,256

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -91.72M
Pretax Income -80.88M
Net Income -80.88M
EBITDA -84.66M
EBIT -91.72M
Earnings Per Share (EPS) -3.25

Balance Sheet

The company has 178.73 million in cash and 259,000 in debt, with a net cash position of 178.47 million or 3.33 per share.

Cash & Cash Equivalents 178.73M
Total Debt 259,000
Net Cash 178.47M
Net Cash Per Share 3.33
Equity (Book Value) 261.13M
Book Value Per Share 9.26
Working Capital 168.57M

Cash Flow

Operating Cash Flow -68.99M
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Pharmasaga does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -0.50%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1